Log In
Print
BCIQ
Print
Print this Print this
 

Fortesta, Fortigel, Itnogen, Tostran, testosterone

Also known as: Tostrex

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionTransdermal 2% testosterone gel
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism in cancer patients; Treat symptoms of male hypogonadism; Treat symptoms of male hypogonadism in patients with Type II diabetes and/or metabolic syndrome
Regulatory Designation

Partner

Bayer AG; Endo International plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today